CandidoEdgardoRivera-LinaresMD

PubMed

• 1 citations
  Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arte...
  Maymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, Kebede H Begna, William J Hogan, Mirinal S Patnaik, Shahrukh K Hashmi, Michelle A Elliott, Hassan Alkhateeb, Omer S ...> ;Blood Cancer Journal. 2023 Aug 11
• 6 citations
  Resolution of acute pulmonary embolism using anticoagulation therapy alone in coronavirus disease 2019.
  Charles A Ritchie, Margaret M Johnson, Justin T Stowell, Hajra Idrees, Beau Toskich, Ricardo Paz-Fumagalli, Seyed Montazeri, Susana Fortich, Camila Franco-Mesa, Peter ...> ;Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2022 May 1
• 1 citations
  Deep vein thrombosis in the setting of Klippel-Trenaunay syndrome and sirolimus treatment.
  Susana Fortich, Charles Ritchie, Marwan Shaikh, Beau Toskich, Candido E. Rivera, Young Erben> ;Journal of Vascular Surgery Cases and Innovative Techniques. 2021 Jul 17
• 3 citations
  Immune-Related Hematologic Adverse Events in the Context of Immune Checkpoint Inhibitor Therapy
  Antoine N. Saliba, Zhuoer Xie, Alexandra Higgins, Xavier Andrade-Gonzalez, Harry E Fuentes-Bayne, Paul J. Hampel, Lionel A. Kankeu Fonkoua, Daniel S. Childs, Sagar Rak...> ;American Journal of Hematology. 2021 Jun 17
• 13 citations
  Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care u...
  Young Erben, Camila Franco-Mesa, Peter Gloviczki, William M. Stone, Alfredo Quinones-Hinojoas, Andrew J. Meltzer, Michelle Lin, Melanie R.F. Greenway, Osman S. Hamid, ...> ;Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2021 Apr 6
• 72 citations
  Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic.
  Robert D. McBane, Victor D. Torres Roldan, Alexander S. Niven, Rajiv K. Pruthi, Pablo Moreno Franco, Jane A. Linderbaum, Ana I. Casanegra, Lance J. Oyen, Damon E. Houg...> ;Mayo Clinic Proceedings. 2020 Nov 1
• 5 citations
  Racial/ethnic differences in patients with anemia and folate deficiency
  Miguel Gonzalez-Velez, Carolyn Mead-Harvey, Heidi E. Kosiorek, Yael Kusne, Candido E. Rivera, Leyla Bojanini, Donald W. Northfelt, Leslie Padrnos> ;International Journal of Laboratory Hematology. 2020 Apr 16
• 9 citations
  Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
  William A. Hammond, Prakash Vishnu, Elisa M. Rodriguez, Zhuo Li, Bhagirathbhai Dholaria, Amanda Shreders, Candido E. Rivera> ;Mayo Clinic Proceedings. 2019 Nov 1
• 24 citations
  Diagnosis and Management of Genetic Iron Overload Disorders
  William C. Palmer, Prakash Vishnu, William Sanchez, Bashar Aqel, Doug Riegert-Johnson, Leigh Ann Kenda Seaman, Andrew W. Bowman, Candido E. Rivera> ;Journal of General Internal Medicine. 2018 Sep 17
• 2 citations
  Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report.
  Candice Baldeo, Candido E. Rivera, Han W Tun, Prakash Vishnu> ;Journal of Blood Medicine. 2018 Jan 19
• 3 citations
  Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey
  Kebede H. Begna, Aref Al-Kali, Michelle A. Elliott, James M. Foran, Naseema Gangat, William J. Hogan, C. Christopher Hook, Jose F. Leis, Mark R. Litzow, Ruben A. Mesa,...> ;American Journal of Hematology. 2017 Jul 21
• 75 citations
  A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis.
  Vikas Gupta, Ruben A. Mesa, Michael W. Deininger, Candido E. Rivera, Shireen Sirhan, Carrie Baker Brachmann, Helen Collins, Jun Kawashima, Yan Xin, Srdan Verstovsek> ;Haematologica. 2017 Jan 1
• 44 citations
  Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib.
  Shaji Kumar, Betsy LaPlant, Craig B. Reeder, Vivek Roy, Alese E. Halvorson, Francis K. Buadi, Morie A. Gertz, P. Leif Bergsagel, Angela Dispenzieri, Melanie Ann Thomps...> ;Blood. 2016 Nov 17
• 28 citations
  von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
  Joseph L. Blackshear, Chad McRee, Robert E. Safford, Peter M. Pollak, Mark E. Stark, Colleen S. Thomas, Candido E. Rivera, Ewa M. Wysokinska, Dong Chen> ;JAMA Cardiology. 2016 May 1
• Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib.
  Kumar SK, LaPlant B, Roy V, Reeder CB, Lacy MQ, Gertz MA, Laumann K, Thompson MA, Witzig TE, Buadi FK, Rivera CE, Mikhael JR, Bergsagel PL, Kapoor P, Hwa L, Fonseca R,...> ;Blood Cancer J. 2015-08-14
• Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phas...
  Nowakowski GS, LaPlant B, Macon WR, Reeder CB, Foran JM, Nelson GD, Thompson CA, Rivera CE, Inwards DJ, Micallef IN, Johnston PB, Porrata LF, Ansell SM, Gascoyne RD, H...> ;J. Clin. Oncol.. 2015-01-20
• 21 citations
  Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.
  Ayalew Tefferi, Stacie Hudgens, Ruben A. Mesa, Robert Peter Gale, Srdan Verstovsek, Francesco Passamonti, Francisco Cervantes, Candido E. Rivera, T. Tencer, Zeba M. Khan> ;Clinical Therapeutics. 2014 Apr 1
• 1 citations
  Clinical Reasoning: A 69-year-old man with leukocytosis and hemorrhagic brain lesions
  Kristin M. Scott, Faithlore P. Gardner, Benjamin H. Eidelman, Candido E. Rivera, David M. Menke, Kevin M. Barrett> ;Neurology. 2014 Jul 1
• 28 citations
  AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström ma...
  Aneel Paulus, Kasyapa S. Chitta, Sharoon Akhtar, David Personett, Kena C. Miller, Kevin J. Thompson, Jennifer M. Carr, Shaji Kumar, Vivek Roy, Stephen M. Ansell, Josep...> ;British Journal of Haematology. 2014 Feb 1
• The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.
  Paulus, A.,Masood, A.,Miller, K. C.,Nazmul H Khan, A. N.,Akhtar, D.,Advani, P.,Foran, J.,Rivera, C.,Roy, V.,Colon-Otero, G.,Chitta, K.,Chanan-Khan, A.> ;Br. J. Haematol.. 2014 Jan 29
• Hodgkin lymphoma of the maxillary sinus: An unusual occurrence.
  Peterson, J.L., Hayostek, C.J., Garvey, C., Menke, D.M., Rivera, C.E.> ;Ear Nose Throat J. 2012 Jan
• Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
  Nowakowski GS, LaPlant B, Habermann TM, Rivera CE, Macon WR, Inwards DJ, Micallef IN, Johnston PB, Porrata LF, Ansell SM, Klebig RR, Reeder CB, Witzig TE> ;Leukemia. 2011-12-01
• Combination of lenalidomide with R-CHOP (R2CHOP) as an initial therapy for aggressive B-cell lymphomas: A phase I/II study.
  Nowakowski GS, Reeder CB, LaPlant B, Habermann TM, Rivera C, Macon WR, Inwards DJ, Micallef INM, Johnston PB, Porrata LF, Ansell SM, Witzig TE> ;J. Clin. Oncol.. 2011-05-20
• Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
  Tefferi, A., Verstovsek, S., Barosi, G., Passamonti, F., Roboz, G.J., Gisslinger, H., Paquette, R.L., Cervantes, F., Rivera, C.E., Deeg, H.J., Thiele, J., Kvasnicka, H...> ;J Clin Oncol. 2009-09-20
• 5-Azacitidine has limited therapeutic activity in myelofibrosis.
  Mesa RA, Verstovsek S, Rivera C, Pardanani A, Hussein K, Lasho T, Wu W, Tefferi A> ;Leukemia. 2009-01-01
• Join now to see all